ClinicalTrials.Veeva

Menu

A Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease The CAD-det Validation Study

A

AusculSciences

Status

Unknown

Conditions

Coronary Artery Disease
Cardiovascular Diseases
Coronary Occlusion
Atherosclerosis

Treatments

Device: CAD-det

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04562142
CAD-det Validation

Details and patient eligibility

About

The purpose of the study is to collect acoustic, ECG, and clinical data from consenting participants, so that AusculSciences can perform analysis on the sounds produced by the heart and determine the accuracy of the CAD-det System for detecting CAD.

Full description

This is a prospective multi-center clinical trial. Using the CAD-det, acoustic and electrical cardiac data will be collected from participants with intermediate pretest probability of CAD who are referred to invasive coronary angiography (ICA). The CAD-det recording will be administered prior to the scheduled ICA procedure. The data collected by CAD-det will be processed using AusculSciences' Data Analysis Application (DAA) to produce a patient's indication for CAD.

Enrollment

395 estimated patients

Sex

All

Ages

19 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Stable
  2. >/= 19 years old
  3. Suspected obstructive CAD
  4. Referred to ICA

Exclusion criteria

  1. Documented CAD or coronary revascularization
  2. Age < 19 years old
  3. Acute coronary syndromes
  4. Congenital heart disease or heart transplantation
  5. Dextrocardia
  6. Uncontrolled irregular heart rhythm (atrial arrhythmia (fibrillation, flutter) or frequent PACs or PVCs (>10/minute))
  7. Resting heart rate > 110 bpm
  8. Known hemodynamically-significant valvular heart disease, audible diastolic murmurs, or hypertrophic or non-ischemic cardiomyopathy
  9. Chest wall deformity or wounds in adhesive application areas
  10. Pregnancy
  11. Unwillingness or inability to provide informed consent or to comply with the study protocol

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

2

Loading...

Central trial contact

Melissa Spero, CRN, CCRP; John Phillips, BSc.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems